Stephen Rose, Ph.D.
Stephen M. Rose, Ph.D.
Chief Research Officer
Foundation Fighting Blindness
Stephen Rose, Ph.D., joined the Foundation Fighting Blindness as the Chief Research Officer in December 2004, and in this position he is responsible for the leadership of the Foundation’s research efforts. He manages day-to-day operations of the Science Department, works closely with the Foundation’s Scientific Advisory Board and Science Liaison Committee, provides overall leadership to its Translational Research Acceleration Program and Preclinical Assessment Centers in collaboration with the FFB clinical arm, the National Neurovision Research Institute (NNRI), and oversees FFB the grants and awards program and the National Eye Evaluation Research clinical trial network (NEER).
Prior to joining the Foundation Dr. Rose was employed at the Office of Biotechnology Activities (OBA) as Director, Division of Clinical Recombinant DNA Research. In this capacity, Dr. Rose served as the Executive Secretary for the Recombinant DNA Advisory Committee and provided oversight and coordination for the recombinant DNA program, working with OBA staff and NIH Institute and Centers Program Staff to help address any issues regarding recombinant DNA, including human gene transfer clinical protocols. In addition, he provided scientific input for the OBA staff supporting the Secretary’s Advisory Committee on Xenotransplantation.
Before joining OBA, Dr. Rose was Director of the Office of Clinical Applications in the Division of Allergy, Immunology and Transplantation at the National Institute of Allergy and Infectious Diseases. He supervised a staff of Medical Officers, nurses, and regulatory experts that provided support for the Division’s clinical trials programs, including the adult and pediatric kidney transplantation cooperative studies, the Inner City Asthma cooperative study, the Autoimmunity Centers of Excellence and clinical trials conducted with the support of individual-investigator grants. Before accepting that position, Dr. Rose was the Chief of the Transplantation Immunobiology Branch in the same NIAID Division and established the kidney transplant clinical trial program.
Dr. Rose received his B.S. in Biology with Honors from American University and took his Ph.D. from the University of Virginia. Upon completion of his doctorate, he was an NIH postdoctoral fellow at Washington University in St. Louis, and then was appointed an Instructor in the Department of Biochemistry at the University of Texas Southwestern Medical School in Dallas. Dr. Rose then moved to the University of New Mexico in the Cancer Research Center as a NIH R01 supported Assistant Professor of Cell Biology. Dr. Rose’s research effort focused on understanding gene expression in the immune system.
Dr. Rose has received several awards throughout his career, including the American Society of Transplantation-Roche Distinguished Service Award for Transplantation, the North American Pediatric Renal Transplant Cooperative Study Group Distinguished Service Award, the U.S. Secretary of Health’s Distinguished Service Award, the NIH Director’s Award, and the NIH Merit Award.